Position in NTLA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,736,286
+$3,870,823 QoQ
Shares Held
339,024
+133.0% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#54
of 330 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PINNACLE ASSOCIATES LTD holds $169,348,366 across 22 Biotechnology names. NTLA ranks #9 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
81,247 | $50,660,754 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
419,752 | $33,282,136 | |
| 3 | CYTK |
Cytokinetics Inc
|
202,440 | $17,245,863 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
170,131 | $13,867,377 | |
| 5 | STTK |
Shattuck Labs, Inc.
|
1,871,442 | $12,987,807 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,375 | $11,114,333 | |
| 7 | INCY |
Incyte Corp
|
68,633 | $7,780,236 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
70,435 | $5,745,382 |
All Filings in NTLA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,736,286 | 339,024 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,865,463 | 145,512 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,341,586 | 149,231 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,827,271 | 163,710 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,588,503 | 169,350 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,527,370 | 214,820 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,567,205 | 220,172 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $5,619,125 | 251,078 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $7,034,747 | 255,716 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||